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Thymectomy is an effective surgical therapy comple-
menting the medical care of patients with myasthenia
gravis. Residual thymic tissue is present in 64% up to 70%
of patients showing partial improvement or no response
after thymectomy.1 Either it is due to a remnant of the
original gland missed during the operation or it develops
from ectopic thymic tissue.2, 3 Completion thymectomy,
carried out by the extended transsternal2, 3 or the maximal
transsternal-transcervical4 approaches, has been advo-
cated after unsuccessful transcervical thymectomy. Video-
assisted thymectomy is being investigated in the belief that
this procedure may also allow a complete removal of the
thymus and the anterior mediastinal and lower cervical
perithymic adipose tissue.5, 6 We have adopted the video-
assisted approach as a less invasive modality to reoperate
on patients with nonthymomatous refractory myasthenia
who did not undergo extended thymectomy initially.
Between December 1995 and December 1996, four
patients with myasthenia gravis, three women and one
man with a mean age of 41 years, underwent video-
assisted completion thymectomy. The mean duration of
myasthenia gravis before the initial operation was 21
months, ranging from 12 to 38 months. The initial oper-
ation was transcervical thymectomy performed by one of
the authors (T.C.M.) in three patients and sternal-splitting
thymectomy performed in a different institution in one.
No patient underwent extended thymectomy originally.
The mean interval between operations was 120 months,
ranging from 72 to 180 months. Informed consent was
obtained from all patients. They were given the main
information regarding the different approaches and the
possible complications. Worthy of note, results of preop-
erative computed tomography and magnetic resonance
imaging were deemed negative or inconclusive regarding
the identification of residual or ectopic thymus. Three
patients had elevated serum titers of antibody to the
acetylcholine receptor, and all had a positive edropho-
nium test and characteristic decreasing responses to low-
frequency repetitive nerve stimulation. At admission, ev-
ery patient was completely disabled. Three patients were
receiving large doses of pyridostigmine bromide (mean
dose 560 mg/day) in combination with prednisone (mean
dose 45 mg/d), and one patient was receiving prednisone
and azathioprine (Table I). All attempts to taper medica-
tion were unsuccessful because of increased fatigue.
Three patients were receiving long-term maintenance
plasma exchange with a mean of 6.25 cycles/year (Table I).
Each patient underwent four exchange cycles over the last
two preoperative weeks to stabilize the clinical condition
and reduce postoperative morbidity. Adjuvant pneumo-
mediastinum was always induced within the last 24 hours
to facilitate the subsequent visualization of the thymic
tissue and the dissection maneuvers.5 The operation was
performed after double-lumen intubation by a four-trocar
access and with the patient lying in a 45-degree off-center
position. Thymectomy routinely included en bloc removal
of the residual thymus, if present, or all of the mediastinal-
lower cervical perithymic adipose tissue (Fig. 1). Thymic
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Fig. 1. Potential sites of ectopic thymic tissue that are
dissected through the left thoracoscopic approach.
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tissue was identified at histologic examination by the
presence of Hassal’s corpuscle or after immunohisto-
chemical staining with cytokeratin and T-cell markers.
The therapeutic effect of completion thymectomy was
established for each patient by comparing the preopera-
tive clinical status with the status at the most recent
follow-up examination. Completion thymectomy was per-
formed by the left video-assisted approach in three pa-
tients and by the right approach in one patient because of
diffuse pleural adhesions on the left side. Mean operative
time was 136 minutes, ranging from 90 to 210 minutes. In
all the patients thymic remnants were found below the left
innominate vein. Mean weight of the removed tissue was
22.7 gm (Table I). No operative deaths nor major mor-
bidity occurred. Mean hospital stay was 3.25 days (range 2
to 5 days). Mean follow-up was 15.0 months (Table I).
Postoperatively, one patient required further plasma ex-
change treatment because of a myasthenic crisis, which
occurred at 6 months. At the most recent follow-up
examination, although no patient was in complete remis-
sion, three had significant improvement in bulbar and
limb function, needing substantially lower doses of corti-
costeroids and anticholinesterase drugs (Table I). Both
patients who had removal of the gross thymic tissue
improved after completion thymectomy.
Standard transcervical and transsternal thymectomy
have been implicated as possible causes of incomplete
thymectomy.2-4 In these cases completion thymectomy
carried out by the extended transsternal2, 3 or maximal
transsternal-transcervical approaches4 proved effective
in ameliorating the effects of refractory myasthenia
gravis.
Similarly we noted that video-assisted completion
thymectomy provided clinical improvement in three of
four patients. In our experience clinical improvement
clearly correlated with the reoperation, because symptoms
eased soon after the operation and the improvement
persisted during the follow-up period. We have always
intentially performed an extended dissection of the resid-
ual thymus and adipose perithymic tissue, and we have
found residual thymic tissue in all our patients.
We believe that the video-assisted approach might be
considered a reliable alternative to the transsternal or
the combined approach for a number of reasons. First,
it is minimally invasive, which however does not seem to
compromise either a complete anatomic thymectomy or
a wide dissection of the anterior mediastinal and lower
cervical adipose tissue. Second, patients with chronic
refractory myasthenia are often receiving high doses of
steroids, which exposes them to an increased risk of
wound healing problems if the transsternal approach is
used. Third, the transsternal reexploration of the ante-
rior mediastinum after transcervical or transsternal
thymectomy might be particularly demanding because
dense adhesions might be found at the site of the
innominate vein. On the other hand, the surgical reex-
posure of the anterior mediastinum can be facilitated by
using a different route, such as the transpleural route.
Finally, the magnified video imaging may allow better
visualization of the vascular and nervous structures and
may help reduce the risk of injuring them during the
dissection maneuvers. To date the combined transster-
nal-transcervical thymectomy represents the gold stan-
dard in terms of extent of dissection and removal of
ectopic thymic tissue in patients with myasthenia.4
However, many patients and neurologists are reluctant
to accept it because of its invasiveness and because its
superiority over other approaches has not yet been
demonstrated. This initial experience suggests that
completion thymectomy is not a contraindication for
the video-assisted approach, which might prove as
effective as open approaches. The role of the video-
assisted thymectomy is evolving and seems to hold
unsuspected potentiality. More detailed studies based
on a wider accrual of patients and longer follow-up are
needed to confirm these findings.
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Table I. Clinical data
Variable Case 1 Case 2 Case 3 Case 4
Thymic tissue location Anterior mediastinal fat Aorto-pulmonary window Anterior mediastinal fat Anterior mediastinal fat
Thymic tissue characteristics Ectopic microscopic Ectopic microscopic Ectopic gross Residual left lower
horn
Weight of removed tissue
(gm); fat 6 thymus
20 28 16 27
Follow-up (mo) 19 17 13 11
Prednisone* (mg/day) 50320 20320 50320 60320
Pyridostigmine* (mg/day) 2403240 — 4803240 9603480
Azathioprine* (mg/kg/day) — 333 — —
Plasma exchange* (cycles/yr) 535 — 1030 1030
Osserman class* IIB3I IIB3IIB IV3IIA IV3I
Outcome Improvement No change Improvement Improvement
*Comparison of the preoperative/postoperative data.
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